Enter assignee name

EPO Patents = 7

Trademarks = 1

Forward Citations = 4

Loading Chart...

3 inventors (with patents filed for the assignee):

Andreas Bergmann (9 out of 109 patents)

Joachim Struck (1 out of 65 patents)

Nils G Morgenthaler (1 out of 21 patents)

9 patents: Sort by Forward Citations

1. 12338281 - Anti-adrenomedullin antibodies and pharmaceutical compositions thereof (2025-06-24),

2. 11673949 - Method of modulating the adrenomedullin (ADM) activity of a patient by administering to the patient an anti-ADM antibody or fragment thereof that specifically binds to mature human ADM (2023-06-13),

3. 10800842 - Anti-adrenomedullin (ADM) monoclonal antibodies and anti-ADM monoclonal antibody fragments that bind to adrenomedullin (2020-10-13),

4. 10227405 - Methods of modulating the activity of adrenomedullin in a subject in need of regulation of fluid balance by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment (2019-03-12),

5. 10221238 - Method of modulating the activity of adrenomedullin in a subject in need of therapeutic intervention for organ dysfunction or organ failure associated with adranomedullin (ADM) activity by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment to the subject (2019-03-05),

6. 9829494 - Methods of treatment using ADM antibodies (2017-11-28),

7. 9402900 - Methods of modulating adrenomedullin by administering an anti-adrenomedullin (ADM) antibody (2016-08-02),

8. 9304127 - Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment for use in therapy (2016-04-05),

9. 9140696 - Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition (2015-09-22),

Adrenomed Ag is a biopharmaceutical company that focuses on the development of innovative treatments for life-threatening conditions. The company's lead product candidate, ADRECIZUMAB, targets the treatment of sepsis and septic shock, which are severe conditions with high mortality rates. Adrenomed's mission is to improve patient outcomes and quality of life through cutting-edge research and development in the field of critical care medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

9 Patents

#6 in Hennigsdorf

#4,035 in Germany

Hennigsdorf, Germany

Adrenomed Ag

Forward Citations = 4

3 inventors:

Andreas Bergmann (9 out of 109 patents)

Joachim Struck (1 out of 65 patents)

Nils G Morgenthaler (1 out of 21 patents)

Please report any incorrect information to support@idiyas.com